CYP2B6 genotype-directed dosing is required for optimal efavirenz exposure in children 3–36 months with HIV infection

Bolton Moore, Carolyn; Capparelli, Edmund V.; Samson, Pearl; More

AIDS . 31(8):1129-1136, May 15, 2017.

Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents

Krogstad, Paul; Patel, Kunjal; Karalius, Brad; More

AIDS . 29(6):683-693, March 27, 2015.

Pubertal onset in children with perinatal HIV infection in the era of combination antiretroviral treatment

Williams, Paige L.; Abzug, Mark J.; Jacobson, Denise L.; More

AIDS . 27(12):1959-1970, July 31, 2013.

Bone mineral density in children and adolescents with perinatal HIV infection

DiMeglio, Linda A.; Wang, JiaJia; Siberry, George K.; More

AIDS . 27(2):211-220, January 14, 2013.

Immunologic and virologic responses to HAART in severely immunocompromised HIV-1-infected children

Essajee, Shaffiq M.; Kim, Mimi; Gonzalez, Charles; More

AIDS . 13(18):2523-2532, December 24, 1999.

The sensitivity of HIV-1 DNA polymerase chain reaction in the neonatal period and the relative contributions of intra-uterine and intra-partum transmission.

Dunn, David T.; Brandt, Carl D.; Krivinet, Anne; More

AIDS . 9(9):F7-F11-984, September 1995.